Status:

Lead Sponsor:

No Sponsor

Collaborating Sponsors:

No Collaborator

Conditions:

No Condition

Eligibility:

All genders

Above 18+

Phase:

1/4

Participant Compensation:

n/a

Eligibility Criteria

Inclusion

    Exclusion

      Key Trial Info

      Start Date :

      Trial Type :

      Clinical Trial

      End Date :

      Estimated Enrollment :

      Patients enrolled

      Trial Details

      Trial ID

      Active Locations (0)

      Enter a location and click search to find clinical trials sorted by distance.

      Page 1 of 0 (0 locations)

      No Results Found

      We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

      The Primary Objective of This Study to Evaluate the Safety and Tolerability of IBI334 and Determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D)and Anti Tumor Activity of IBI334. | DecenTrialz